SciELO - Scientific Electronic Library Online

 
vol.11 número4Identificación del riesgo de trombosis en pacientes con padecimientos oncológicos ambulatorios en quimioterapiaCirugía oncoplástica como alternativa en el tratamiento de pacientes con cáncer de mama índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Finlay

versión On-line ISSN 2221-2434

Resumen

GONZALEZ FERNANDEZ, Hailyn et al. Clinical-epidemiological Characterization of Ovarian Cancer. Rev. Finlay [online]. 2021, vol.11, n.4, pp. 359-370.  Epub 30-Dic-2021. ISSN 2221-2434.

Background:

ovarian cancer constitutes a public health problem in Cuba and the world due to its high morbidity and mortality.

Objective:

to characterize the patients diagnosed with ovarian cancer treated at the Gynecol Oncology Service of the Celestino Hernández Robau Teaching University Hospital in the period 2015 - 2018.

Method:

a descriptive cross-sectional study was carried out with a sample of 71 patients diagnosed with ovarian cancer at the Celestino Hernández Robau Teaching University Hospital. Variables were considered: age, level of education, smoking, obesity, family pathological history of ovarian cancer, gynecostal history, histological classification, clinical stage, monospecific treatment and response to primary treatment. Absolute and relative frequencies were determined.

Results:

patients between 50-59 years (36.6 %), multiparous (92 %), in clinical stage IIIC with 35.22 %, serous adenocarcinomas represented the most frequent histological type (64.79 %). Suboptimal surgery was performed in 52.11 % and adjuvant chemotherapy in 45.07 %. 35 % of the patients achieved a complete response to the initial treatment.

Conclusions:

the results obtained behave, in general, according to epidemiological patterns reported internationally. Patients between 50-59 years of age, multiparous, in clinical stage IIIC and with serous adenocarcinomas are prevalent. Surgery and chemotherapy are standard treatments. Complete response was obtained in most patients after initial treatment.

Palabras clave : ovarian cancer; morbidity; mortality; treatments.

        · resumen en Español     · texto en Español     · Español ( pdf )